Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads In Oncology Oncology for January/February 2021 Younger adults present with more advanced esophageal adenocarcinoma, More must reads Oncology for November/December 2020 Two different radiation boost strategies reduce local failures in NSCLC, Long-term APBI cosmetic, toxicity data reported WBI has the edge Practice-confirming results, Caregiver burden of outpatient ASCT for multiple myeloma comparable with inpatient transplant, Geography and behaviors linked to early-onset colorectal cancer survival in U.S. women, Cryoballoon, cryospray found equivalent for eradicating Barret’s esophagus, More must readsOncology for September/October 2020 Statins may lower risk of colorectal cancer, Socioeconomic factors affect survival of multiple myeloma patients, National lung cancer screening guidelines may miss younger African American individuals at high risk, Combined features of benign breast disease tied to breast cancer risk, Older adults with multiple myeloma face heavy burden of care, More must readsOncology for July/August 2020 Age, other risk factors predict length of MM survival, Large study finds no link between TCI use, skin cancer in patients with AD, Incidence, prognosis of second lung cancers support long-term surveillance, Polygenic risk score may predict VTE in adolescents, but not adults, with ALL, BALL score predicts benefit from ibrutinib therapy in relapsed/refractory CLL patients, More must readsOncology for May/June 2020 Combo drug improves survival in older patients with high-risk/secondary AML, Venetoclax plus LDAC tops LDAC alone in AML, Endoscopic full-thickness resection of colorectal lesions appears safe and effective, Azacitidine plus enasidenib improves response, but not survival, in mIDH2 AML, Eczema may increase lymphoma risk, cohort studies suggest, More must readsPages1 2 3 4 5 6 7 last »
